HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 204 filers reported holding HERON THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 2.25 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $300 | -75.6% | 291,300 | -72.5% | 0.00% | -50.0% |
| Q2 2023 | $1,229 | -28.7% | 1,059,100 | -7.2% | 0.00% | 0.0% |
| Q1 2023 | $1,723 | +111.2% | 1,140,836 | +249.4% | 0.00% | +100.0% |
| Q4 2022 | $816 | -100.0% | 326,500 | +100.8% | 0.00% | -66.7% |
| Q1 2021 | $2,636,000 | +31.9% | 162,600 | +20.6% | 0.00% | +50.0% |
| Q3 2020 | $1,998,000 | -43.4% | 134,800 | -43.8% | 0.00% | -33.3% |
| Q2 2020 | $3,527,000 | -71.4% | 239,800 | -77.2% | 0.00% | -75.0% |
| Q1 2020 | $12,349,000 | +190.3% | 1,051,892 | +481.2% | 0.01% | +300.0% |
| Q4 2019 | $4,254,000 | +134.9% | 181,000 | +85.8% | 0.00% | +50.0% |
| Q2 2019 | $1,811,000 | -57.3% | 97,400 | -27.4% | 0.00% | -50.0% |
| Q3 2018 | $4,244,000 | -72.2% | 134,100 | -65.8% | 0.00% | -50.0% |
| Q2 2018 | $15,249,000 | +956.0% | 392,500 | +391.9% | 0.01% | +300.0% |
| Q4 2017 | $1,444,000 | -3.7% | 79,800 | +65.9% | 0.00% | -33.3% |
| Q2 2015 | $1,499,000 | – | 48,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 8,648,252 | $238,692,000 | 35.08% |
| Broadfin Capital, LLC | 1,581,416 | $43,647,000 | 6.80% |
| Tavio Capital LLC | 351,729 | $9,708,000 | 4.58% |
| Mesirow Financial Investment Management, Inc. | 33,389 | $922,000 | 3.88% |
| Rubric Capital Management LP | 1,510,008 | $41,676,000 | 3.88% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,666,229 | $45,988,000 | 3.63% |
| First Light Asset Management, LLC | 473,275 | $13,062,000 | 2.87% |
| Asymmetry Capital Management, L.P. | 77,346 | $2,135,000 | 2.67% |
| Copernicus Capital Management, LLC | 108,000 | $2,981,000 | 2.38% |
| BRIDGER MANAGEMENT, LLC | 1,277,560 | $35,261,000 | 2.14% |